• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Should en bloc esophagectomy be the standard of care for esophageal carcinoma?整块食管切除术应成为食管癌的标准治疗方法吗?
Ann Surg. 2001 Nov;234(5):581-7. doi: 10.1097/00000658-200111000-00001.
2
Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.食管癌鳞状细胞癌和腺癌的三野淋巴结清扫术。
Ann Surg. 2002 Aug;236(2):177-83. doi: 10.1097/00000658-200208000-00005.
3
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.透壁性食管腺癌的淋巴结状态及整块食管切除术后的结局
J Thorac Cardiovasc Surg. 1999 May;117(5):960-8. doi: 10.1016/S0022-5223(99)70377-6.
4
Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.食管鳞状细胞癌扩大食管切除术加三野淋巴结清扫术的临床疗效
Am J Surg. 2005 Jan;189(1):98-109. doi: 10.1016/j.amjsurg.2004.10.001.
5
Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus.评估胸段食管癌根治性切除术中淋巴结清扫的合理范围。
Surg Today. 1997;27(1):3-8. doi: 10.1007/BF01366932.
6
Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus.胸段食管癌行食管次全切除术加三野淋巴结清扫术的长期结果。
Ann Surg. 1994 Mar;219(3):310-6. doi: 10.1097/00000658-199403000-00012.
7
Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?临床 T1N0 胸段食管鳞癌手术中能否安全省略肝总动脉淋巴结清扫术?
Dis Esophagus. 2013 Apr;26(3):272-5. doi: 10.1111/j.1442-2050.2012.01361.x. Epub 2012 May 29.
8
Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.上食管鳞癌的淋巴结转移模式和生存情况。
Ann Thorac Surg. 2011 Sep;92(3):1091-7. doi: 10.1016/j.athoracsur.2011.03.093. Epub 2011 Jun 25.
9
[Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].[胸腔镜食管癌根治术中纵隔淋巴结清扫的可行性与安全性]
Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):855-9. doi: 10.3760/cma.j.issn.0253-3766.2012.11.013.
10
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.在根治性食管切除术和三野淋巴结清扫术后,颈淋巴结转移在胸段食管鳞状细胞癌中被归类为区域淋巴结分期。
BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.

引用本文的文献

1
Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.基于预后列线图的生存风险分层,以确定可能从术后辅助治疗中获益的食管鳞癌患者。
BMC Cancer. 2024 Oct 29;24(1):1330. doi: 10.1186/s12885-024-13085-w.
2
Experiences in reverse sequence esophagectomy: a promising alternative for esophageal cancer surgery.逆行序食管癌切除术的经验:食管癌手术的一种有前途的替代方法。
Surg Endosc. 2023 Sep;37(9):6749-6760. doi: 10.1007/s00464-023-10120-y. Epub 2023 May 22.
3
Short-term outcome for high-risk patients after esophagectomy.高危患者食管切除术后的短期预后。
Dis Esophagus. 2022 Dec 31;36(1). doi: 10.1093/dote/doac028.
4
Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort THE for locally advanced GEJC.经食管裂孔食管切除术治疗胃食管结合部局部进展期腺癌:单中心队列研究的术后和肿瘤学结果。
World J Surg Oncol. 2022 Mar 6;20(1):70. doi: 10.1186/s12957-022-02537-x.
5
Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.胸下段食管鳞癌术后淋巴复发分布与靶区勾画:真实世界研究。
Radiat Oncol. 2022 Mar 5;17(1):47. doi: 10.1186/s13014-022-01987-7.
6
Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?食管癌淋巴结清扫充分作为质量指标:与治疗方法有关吗?
Ann Surg Oncol. 2020 Oct;27(11):4443-4456. doi: 10.1245/s10434-020-08578-4. Epub 2020 Jun 9.
7
Extent of lymphadenectomy for Barrett's cancer.巴雷特食管癌的淋巴结清扫范围。
Transl Gastroenterol Hepatol. 2019 May 24;4:36. doi: 10.21037/tgh.2019.05.07. eCollection 2019.
8
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.瘤周切除胶质母细胞瘤与改善预后独立相关。
Neurosurgery. 2020 Jan 1;86(1):112-121. doi: 10.1093/neuros/nyz008.
9
Long-Term Survival and Tumor Recurrence in Patients with Superficial Esophageal Cancer after Complete Non-Curative Endoscopic Resection: A Single-Center Case Series.浅表性食管癌患者接受非根治性内镜完整切除术后的长期生存及肿瘤复发情况:一项单中心病例系列研究
Clin Endosc. 2018 Sep;51(5):470-477. doi: 10.5946/ce.2018.025. Epub 2018 Jun 1.
10
The benefits and limitations of robotic assisted transhiatal esophagectomy for esophageal cancer.机器人辅助经裂孔食管癌切除术的益处与局限性
J Vis Surg. 2016 Sep 8;2:156. doi: 10.21037/jovs.2016.09.01. eCollection 2016.

本文引用的文献

1
Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study.食管癌:美国外科医师学会患者护理评估研究结果
J Am Coll Surg. 2000 May;190(5):562-72; discussion 572-3. doi: 10.1016/s1072-7515(00)00238-6.
2
Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy.影响接受艾弗·刘易斯食管胃切除术患者发病率、死亡率及生存率的因素。
Ann Surg. 2000 May;231(5):635-43. doi: 10.1097/00000658-200005000-00003.
3
Transhiatal esophagectomy: clinical experience and refinements.经胸食管切除术:临床经验与改进
Ann Surg. 1999 Sep;230(3):392-400; discussion 400-3. doi: 10.1097/00000658-199909000-00012.
4
The rationale for radical resection.
Surg Oncol Clin N Am. 1999 Apr;8(2):295-305.
5
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.局部食管癌化疗后手术与单纯手术的比较。
N Engl J Med. 1998 Dec 31;339(27):1979-84. doi: 10.1056/NEJM199812313392704.
6
En bloc esophagectomy improves survival for stage III esophageal cancer.整块食管切除术可提高Ⅲ期食管癌患者的生存率。
J Thorac Cardiovasc Surg. 1997 Dec;114(6):948-55; discussion 955-6. doi: 10.1016/S0022-5223(97)70009-6.
7
A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma.经裂孔与经胸入路切除治疗食管下段癌的前瞻性随机对照研究
Am J Surg. 1997 Sep;174(3):320-4. doi: 10.1016/s0002-9610(97)00105-0.
8
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial.术前化疗与单纯手术治疗食管鳞状细胞癌的前瞻性随机试验。
J Thorac Cardiovasc Surg. 1997 Aug;114(2):210-7. doi: 10.1016/S0022-5223(97)70147-8.
9
Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria.食管癌和贲门癌的食管胃切除术:采用改进的分期标准,对连续三个八年期间标准切除术后的结果和发现进行比较。
J Thorac Cardiovasc Surg. 1997 May;113(5):836-46; discussion 846-8. doi: 10.1016/S0022-5223(97)70256-3.
10
Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial.经裂孔入路或开胸食管切除术:一项前瞻性随机试验。
Br J Surg. 1993 Mar;80(3):367-70. doi: 10.1002/bjs.1800800335.

整块食管切除术应成为食管癌的标准治疗方法吗?

Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

作者信息

Altorki N, Skinner D

机构信息

Weill Medical College of Cornell University, Department of Cardiothoracic Surgery, New York, New York 10021, USA.

出版信息

Ann Surg. 2001 Nov;234(5):581-7. doi: 10.1097/00000658-200111000-00001.

DOI:10.1097/00000658-200111000-00001
PMID:11685019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1422081/
Abstract

OBJECTIVE

To determine the impact of radical node dissection on the recurrence patterns and survival rates of patients with carcinoma of the esophagus.

SUMMARY BACKGROUND DATA

The role of esophagectomy with radical lymphadenectomy in the treatment of esophageal cancer is controversial. Most centers favor a limited operation with no attempt at nodal clearance. However, disease recurrence and patient survival rates remain dismal with or without preoperative therapy. The authors postulate that a more radical node dissection would reduce local failure rates and enhance survival.

METHODS

One hundred eleven patients with esophageal cancer underwent en bloc esophagectomy with radical lymph node dissection between 1988 and 1998. In 90% of patients the procedure was applied nonselectively and without any preoperative therapy. Patients were prospectively followed up for recurrence patterns and survival.

RESULTS

The 5-year survival rate including noncancer deaths was 40%. The 5-year survival rates for patients with stage 1, 2A, 2B, 3, and 4 disease were 78%, 72%, 0%, 39%, and 27%, respectively. Forty percent of patients had node-negative disease (5-year survival rate, 75%), and 60% had nodal metastases (5-year survival rate, 26%). Recurrence occurred in 39% of patients and was local in only 8%.

CONCLUSIONS

Radical esophagectomy results in superior overall and stage-specific 5-year survival rates. Extensive node dissection has a positive impact on survival rates, particularly in patients with nodal metastases.

摘要

目的

确定根治性淋巴结清扫术对食管癌患者复发模式和生存率的影响。

总结背景数据

食管癌切除联合根治性淋巴结清扫术在食管癌治疗中的作用存在争议。大多数中心倾向于进行有限的手术,不尝试进行淋巴结清扫。然而,无论有无术前治疗,疾病复发率和患者生存率仍然很低。作者推测,更彻底的淋巴结清扫术将降低局部失败率并提高生存率。

方法

1988年至1998年间,111例食管癌患者接受了食管癌整块切除及根治性淋巴结清扫术。90%的患者接受了非选择性手术,且未进行任何术前治疗。对患者进行前瞻性随访,观察复发模式和生存率。

结果

包括非癌症死亡患者在内的5年生存率为40%。1期、2A期、2B期、3期和4期疾病患者的5年生存率分别为78%、72%、0%、39%和27%。40%的患者淋巴结阴性(5年生存率,75%),60%的患者有淋巴结转移(5年生存率,26%)。39%的患者出现复发,其中仅8%为局部复发。

结论

根治性食管癌切除术可提高总体和各分期的5年生存率。广泛的淋巴结清扫术对生存率有积极影响,尤其是对有淋巴结转移的患者。